We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Scientists Use Cloud-Based Supercomputing and AI to Develop COVID-19 Treatments and Vaccine Models

By HospiMedica International staff writers
Posted on 16 Sep 2020
Print article
Image: Covax-19 (Photo courtesy of Vaxine Pty Ltd.)
Image: Covax-19 (Photo courtesy of Vaxine Pty Ltd.)
A team of scientists from a vaccination biotech company have used cloud-based supercomputing and artificial intelligence (AI) to develop COVID-19 treatments and vaccine models.

The research team from Vaxine Pty Ltd. (Adelaide, Australia) used computer modelling on the coronavirus spike protein to rapidly design a synthetic COVID-19 vaccine. The Vaxine team was able to design, manufacture and advance their Covax-19 vaccine into human trials in under five months in a process that normally would take up to 15 years. The team is also using similar techniques for other projects, including a new treatment for respiratory complications of COVID-19, a preventive nasal spray, and a rapid response test to predict how severely the disease will progress.

Recently, the Vaxine research group released a list of up to 80 new potential candidate drugs against the COVID-19 virus. The possible therapies were identified using cloud-based supercomputer programs used by Vaxine in its vaccination research modelling, allowing other researchers to further investigate their potential. Using the genetic sequence of COVID-19, the team built three dimensional molecular structures of key COVID-19 proteins that were then used to screen existing drugs and natural remedies for potential activity against the COVID-19 protease protein. The team used high performance cloud computing services provided by Oracle under a research grant to Flinders University (Adelaide, South Australia) that enabled the team to rapidly screen for potential drugs against COVID-19.

“Thanks to our unique ability to run computer simulations on the virus before it is even fully characterized, we were able to dramatically speed up the ability to design our Covax-19 vaccine,” said Flinders University Professor Nikolai Petrovsky, Research Director of Vaxine. “The vaccine based on the synthetic spike protein was then manufactured in insect cell cultures before being combined with our Vaxine Advax adjuvant, which is used to turbocharge the vaccine and make it more effective.”

“It is exciting to be at the forefront of global COVID-19 science efforts, applying all the latest cutting edge methods including artificial intelligence and high performance cloud computing to create potential pandemic drugs and vaccines as part of the Vaxine team,” said Dr. Sakshi Piplani, who leads Vaxine’s bioinformatics team.

Related Links:
Vaxine Pty Ltd.
Flinders University



Print article
IIR Middle East

Channels

Critical Care

view channel
Image: Size comparison of the new mTP laser array (Photo courtesy of Rockley)

New Chip Technology Paves Way for Tiny Wearable Devices to Detect and Measure Biomarkers

Scientists have developed what is believed to be the world’s first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications. This groundbreaking achievement by Rockley Photonics... Read more

Surgical Techniques

view channel
Image: The EASEE minimally invasive brain pacemaker has received CE certification (Photo courtesy of Precisis GmbH)

World's First Minimally Invasive Brain Pacemaker Treats Epilepsy

The treatment of patients with epilepsy always begins with medication. However, for decades there has unfortunately been a consistently large group of around 30% of all patients for whom pharmacological... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.